Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:939 (23 October), doi:10.1136/bmj.329.7472.939-c
Owen Dyer
London
| The first 150 words of the full text of this article appear below. |
It looks increasingly certain that the United States will enter the influenza season seriously short of vaccine, after a Food and Drug Administration team visiting Britain declared that 48 million potentially contaminated units of vaccine were 38unsafe for use.
|
|
People queue for flu vaccination at a supermarket in Rhode Island Credit: VICTORIA AROCHO/AP
|
The vaccines represented half of the United States's planned supply for this year. The manufacturer, the Chiron Corporation of California, had to close its Liverpool factory after its licence to produce Fluvirin vaccine was suspended by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (
BMJ
2004;329: 876
The vaccines have already been produced, but regulators fear that they are contaminated by the bacterium Serratia marcescens. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research, visited the Liverpool factory last week to discover if any of
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?